Terns Pharmaceuticals, Inc. (TERN) Operating Lease, Right-of-Use Asset USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Terns Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2021 to 2024.
  • Terns Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $369 K, a 59% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $369 K -$532 K -59% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $523 K -$524 K -50% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 $671 K -$523 K -43.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $756 K -$489 K -39.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $901 K -$475 K -34.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.05 M +$1.05 M Dec 31, 2022 10-K 2024-03-14
Q3 2022 $1.19 M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.25 M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.38 M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.